Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. ZJYL
ZJYL logo

ZJYL Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
0.140
Open
0.140
VWAP
0.12
Vol
1.15M
Mkt Cap
22.28M
Low
0.110
Amount
140.53K
EV/EBITDA(TTM)
13.41
Total Shares
156.55M
EV
11.42M
EV/OCF(TTM)
3.93
P/S(TTM)
1.08
Jin Medical International Ltd is a holding company mainly engaged in the design and manufacturing of wheelchairs. The Company, through its wholly owned subsidiaries, is primarily engaged in the design, development, manufacturing and sales of wheelchair and other living aids products to be used by people with disabilities or impaired mobility. The Company's wheelchair product category includes mid, high and low-end wheelchairs. The wheelchair components include wheels and brakes, which are sold to customers for after-sales service. The living aids product category consists of oxygen concentrators, bath aids and rehabilitative devices. The Company mainly distributes its products in domestic and overseas markets.
Show More

Events Timeline

(ET)
2025-07-16
05:41:21
Jin Medical launches production at Plant No. 3
select
2025-05-06 (ET)
2025-05-06
17:47:51
Jin Medical receives noncompliance notification from Nasdaq
select
2024-10-10 (ET)
2024-10-10
08:11:23
Jin Medical announces initiation of construction of new manufacturing facility
select

News

Newsfilter
8.5
03-11Newsfilter
PinnedJin Medical International Approves Share Combination Plan
  • Share Combination Plan: Jin Medical International's Board of Directors has approved a 1-for-20 share combination aimed at enhancing the company's capital structure by reducing the number of outstanding shares, thereby improving compliance with Nasdaq listing requirements and market performance.
  • Authorized Capital Reclassification: The reclassification divides the company's authorized capital into 45 million Class A ordinary shares and 5 million Class B ordinary shares, reflecting a strategic adjustment in capital structure that is expected to attract more investor interest.
  • Market Trading Arrangement: The stock combination will take effect on March 16, 2026, with Class A ordinary shares continuing to trade on Nasdaq under a consolidation-adjusted basis, and the new CUSIP number will be G5140V120, ensuring a smooth transition for investors.
  • Production Facility Expansion: Jin Medical's manufacturing facilities in Jiangsu and Anhui provinces will total 660,000 square feet, indicating the company's ongoing efforts to expand production capacity and market share to meet the growing demand from the disabled and elderly markets.
NASDAQ.COM
8.5
14:04 PMNASDAQ.COM
Jin Medical International Approves 1-for-20 Reverse Stock Split
  • Reverse Stock Split Plan: Jin Medical International Ltd. has approved a 1-for-20 reverse stock split, set to take effect on March 16, 2026, which will significantly reduce the number of outstanding shares as part of its effort to regain compliance with Nasdaq listing requirements.
  • Share Count Reduction: Following the split, the number of issued Class A shares will decrease from approximately 136.5 million to about 6.8 million, while Class B shares will shrink from 20 million to 1 million, thereby optimizing the company's capital structure.
  • Capital Structure Reclassification: The company has completed the reclassification of its authorized capital into dual-class shares and filed updated corporate documents with regulators in the Cayman Islands to reflect these changes, indicating a focus on strengthening its long-term capital framework.
  • Stock Price Fluctuation: ZJYL shares have traded between $0.11 and $1.02 over the past year, currently priced at $0.11, down 18.90%, reflecting market caution regarding the company's future prospects.
seekingalpha
8.5
13:12 PMseekingalpha
Jin Medical International Approves 1-for-20 Reverse Stock Split
  • Reverse Stock Split Decision: Jin Medical International (ZJYL) has approved a 1-for-20 reverse stock split, set to take effect on March 16, 2026, which is expected to significantly reduce the total number of authorized and issued shares, potentially impacting shareholder structure profoundly.
  • Share Count Changes: Following the reverse split, Class A shares will decrease from 136.55 million to 6.83 million, while Class B shares will drop from 20 million to 1 million, a change that will notably increase the market value per share and may influence investor holding decisions.
  • Equity Structure Reclassification: The company has reclassified its share structure into dual classes, establishing 45 million Class A shares and 5 million Class B shares, aiming to enhance governance and operational flexibility, thereby increasing market appeal.
  • Market Reaction: Following the announcement of the reverse split, ZJYL's shares fell 16% in premarket trading, reflecting a cautious market sentiment regarding this decision, which could affect investor confidence and future financing capabilities.
PRnewswire
2.0
03-11PRnewswire
Jin Medical International Announces Share Combination Plan
  • Share Combination Plan: Jin Medical International's Board of Directors has approved a 1-for-20 share combination aimed at enhancing the company's capital structure by reducing the number of outstanding shares, thereby improving compliance with Nasdaq listing requirements and market performance.
  • Authorized Capital Reclassification: Following the authorization from the extraordinary general meeting on January 30, 2026, the company will reclassify its authorized capital into Class A and Class B ordinary shares, totaling $50,000, reflecting strategic planning for future growth.
  • Shareholder Structure Change: Post-combination, the number of outstanding Class A ordinary shares will decrease from 136,547,100 to 6,827,355, while Class B ordinary shares will drop from 20,000,000 to 1,000,000, significantly increasing per-share value and boosting investor confidence.
  • New Trading Code Effective: The share combination will take effect on March 16, 2026, with Class A ordinary shares continuing to trade on Nasdaq under the existing symbol
NASDAQ.COM
2.0
01-28NASDAQ.COM
Healthcare Stocks Surge in After-Hours Trading
  • Acumen Pharmaceuticals Surge: Acumen Pharmaceuticals, Inc. (ABOS) advanced 8.09% in after-hours trading to close at $2.94, adding $0.22, indicating strong investor confidence in its growth prospects.
  • Fulgent Genetics Rise: Fulgent Genetics, Inc. (FLGT) rose 5.98% to $28.90 in after-hours trading, gaining $1.63, reflecting market optimism regarding its business outlook.
  • Fractyl Health Growth: Fractyl Health, Inc. (GUTS) climbed 5.19% to $2.23 after hours, up $0.11, suggesting that its potential in the biotech sector is being recognized by the market.
  • Coeptis Therapeutics Increase: Coeptis Therapeutics Holdings, Inc. (COEP) added 4.14% to finish at $13.85, gaining $0.55 in after-hours trading, demonstrating investor support for its strategic direction.
PRnewswire
1.0
01-26PRnewswire
Jin Medical International to Host Strategic Discussion
  • Executive Strategic Discussion: Jin Medical's CEO and management team will host a strategic discussion on February 1, 2026, at 8 PM EST, aimed at sharing recent strategic priorities and long-term growth considerations, which is expected to enhance investor confidence.
  • Website Update Launch: The company has launched its updated corporate website, providing a webcast of the strategic discussion, thereby increasing information transparency and offering investors a more convenient channel to access company updates.
  • Manufacturing Capacity Expansion: Jin Medical operates two manufacturing plants in Jiangsu Province totaling approximately 230,000 square feet and is establishing a new facility of 430,000 square feet in Chuzhou, Anhui Province, demonstrating the company's proactive response to future market demand.
  • International Distribution Network: Jin Medical collaborates with over 40 domestic distributors and more than 20 international distributors, primarily selling over 30 lightweight and ergonomic wheelchair models to Japan and China, further solidifying its leadership position in the rehabilitation medical equipment market.

Valuation Metrics

The current forward P/E ratio for Jin Medical International Ltd (ZJYL.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Jin Medical International Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

stocks under 2$
Intellectia · 732 candidates
Price: $0.00 - $2.00List Exchange: XNYS, XNAS, XASE
Ticker
Name
Market Cap$
top bottom
TIRX logo
TIRX
Tian Ruixiang Holdings Ltd
6.37M
STFS logo
STFS
Star Fashion Culture Holdings Ltd
4.80M
PTLE logo
PTLE
PTL Ltd
10.47M
CENN logo
CENN
Cenntro Inc (The Corporation)
11.05M
JTAI logo
JTAI
Jet.AI Inc
4.96M
WCT logo
WCT
Wellchange Holdings Co Ltd
20.03M
Help me find stocks that are under 2.00
Intellectia · 531 candidates
Region: USPrice: <= $2.00List Exchange: XNYS, XNAS, XASE
Ticker
Name
Market Cap$
top bottom
APLT logo
APLT
Applied Therapeutics Inc
14.24M
SXTC logo
SXTC
China SXT Pharmaceuticals Inc
11.42M
ZJYL logo
ZJYL
Jin Medical International Ltd
25.25M
CENN logo
CENN
Cenntro Inc (The Corporation)
13.35M
BURU logo
BURU
NUBURU Inc
76.36M
UGRO logo
UGRO
urban-gro Inc
3.10M
Stocks under 1 dollar
Intellectia · 291 candidates
Price: $0.00 - $1.00List Exchange: XNYS, XNAS, XASE
Ticker
Name
Market Cap$
top bottom
MTEN logo
MTEN
Mingteng International Corp Inc
4.13M
ATPC logo
ATPC
Agape ATP Corp
3.93M
SXTC logo
SXTC
China SXT Pharmaceuticals Inc
10.96M
APLT logo
APLT
Applied Therapeutics Inc
15.14M
MKDW logo
MKDW
MKDWELL Tech Inc
12.07M
PTLE logo
PTLE
PTL Ltd
11.70M
Stocks under 1$
Intellectia · 374 candidates
Price: <= $1.00
Ticker
Name
Market Cap$
top bottom
MTEN logo
MTEN
Mingteng International Corp Inc
4.13M
ATPC logo
ATPC
Agape ATP Corp
3.93M
SXTC logo
SXTC
China SXT Pharmaceuticals Inc
10.96M
APLT logo
APLT
Applied Therapeutics Inc
15.14M
MKDW logo
MKDW
MKDWELL Tech Inc
12.07M
PFSA logo
PFSA
Profusa Inc
9.85M
stock under 5$ bulish for tomorrow
Intellectia · 447 candidates
Price: <= $5.00
Ticker
Name
Market Cap$
top bottom
SXTC logo
SXTC
China SXT Pharmaceuticals Inc
11.70M
ZJYL logo
ZJYL
Jin Medical International Ltd
19.82M
WCT logo
WCT
Wellchange Holdings Co Ltd
22.89M
PASW logo
PASW
Ping An Biomedical Co Ltd
3.72M
JOB logo
JOB
GEE Group Inc
23.64M
UGRO logo
UGRO
urban-gro Inc
3.53M
best penny stock under 10 dollars today
Intellectia · 1578 candidates
Price: <= $10.00Market Cap Category: micro, nano
Ticker
Name
Market Cap$
top bottom
MTEN logo
MTEN
Mingteng International Corp Inc
5.55M
ATPC logo
ATPC
Agape ATP Corp
4.10M
SXTC logo
SXTC
China SXT Pharmaceuticals Inc
11.70M
CCTG logo
CCTG
CCSC Technology International Holdings Ltd
3.84M
APLT logo
APLT
Applied Therapeutics Inc
14.63M
PTLE logo
PTLE
PTL Ltd
10.48M
any stock
Intellectia · 10 candidates
Rsi Category: oversoldRelative Vol: >= 2Beta: HighRisk
Ticker
Name
Market Cap$
top bottom
WIX logo
WIX
Wix.Com Ltd
4.37B
AUDC logo
AUDC
AudioCodes Ltd
235.44M
PMVP logo
PMVP
PMV Pharmaceuticals Inc
56.40M
ZJYL logo
ZJYL
Jin Medical International Ltd
19.82M
CLBT logo
CLBT
Cellebrite DI Ltd
3.85B
SHOP logo
SHOP
Shopify Inc
180.36B
stocks under $0.50 with an rsi under 20
Intellectia · 33 candidates
Price: <= $0.50Rsi Category: oversold
Ticker
Name
Market Cap$
top bottom
MTEN logo
MTEN
Mingteng International Corp Inc
5.55M
ATPC logo
ATPC
Agape ATP Corp
4.10M
SXTC logo
SXTC
China SXT Pharmaceuticals Inc
11.70M
CCTG logo
CCTG
CCSC Technology International Holdings Ltd
3.84M
APLT logo
APLT
Applied Therapeutics Inc
14.63M
ZJYL logo
ZJYL
Jin Medical International Ltd
19.82M
stocks under $1 with an rsi under 20
Intellectia · 53 candidates
Price: <= $1.00Rsi Category: oversold
Ticker
Name
Market Cap$
top bottom
AIIO logo
AIIO
Robo.ai Inc
89.22M
PSTV logo
PSTV
Plus Therapeutics Inc
52.05M
HURA logo
HURA
TuHURA Biosciences Inc
41.71M
XLO logo
XLO
Xilio Therapeutics Inc
40.33M
POM logo
POM
PomDoctor Ltd
35.21M
OTLK logo
OTLK
Outlook Therapeutics Inc
32.44M
200 usd to start now wats my first step
Intellectia · 3944 candidates
Region: USPrice: $0.00 - $200.00
Ticker
Name
Market Cap$
top bottom
SXTC logo
SXTC
China SXT Pharmaceuticals Inc
11.70M
APLT logo
APLT
Applied Therapeutics Inc
14.63M
ZJYL logo
ZJYL
Jin Medical International Ltd
19.82M
CENN logo
CENN
Cenntro Inc (The Corporation)
12.95M
BURU logo
BURU
NUBURU Inc
77.15M
WORX logo
WORX
Scworx Corp
2.85M

Whales Holding ZJYL

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Jin Medical International Ltd (ZJYL) stock price today?

The current price of ZJYL is 0.1162 USD — it has decreased -18.27

What is Jin Medical International Ltd (ZJYL)'s business?

Jin Medical International Ltd is a holding company mainly engaged in the design and manufacturing of wheelchairs. The Company, through its wholly owned subsidiaries, is primarily engaged in the design, development, manufacturing and sales of wheelchair and other living aids products to be used by people with disabilities or impaired mobility. The Company's wheelchair product category includes mid, high and low-end wheelchairs. The wheelchair components include wheels and brakes, which are sold to customers for after-sales service. The living aids product category consists of oxygen concentrators, bath aids and rehabilitative devices. The Company mainly distributes its products in domestic and overseas markets.

What is the price predicton of ZJYL Stock?

Wall Street analysts forecast ZJYL stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ZJYL is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Jin Medical International Ltd (ZJYL)'s revenue for the last quarter?

Jin Medical International Ltd revenue for the last quarter amounts to 34.23 USD, increased 5.98

What is Jin Medical International Ltd (ZJYL)'s earnings per share (EPS) for the last quarter?

Jin Medical International Ltd. EPS for the last quarter amounts to USD, decreased

How many employees does Jin Medical International Ltd (ZJYL). have?

Jin Medical International Ltd (ZJYL) has 273 emplpoyees as of March 12 2026.

What is Jin Medical International Ltd (ZJYL) market cap?

Today ZJYL has the market capitalization of 22.28M USD.